Division Faculty


Faculty Profile:

Mark Chesnutt, MD

Associate Professor of Medicine, Division of Pulmonary & Critical Care Medicine, OHSU
Director, Hereditary Hemorrhagic Telangiectasia Center of Excellence
Staff, Dotter Interventional Instititute, OHSU
Medical Director of Critical Care, Portland VA Medical Center
E-mail: chesnutm@ohsu.edu


Degrees:
  • BS - Pacific Lutheran University, 1982
  • MD - Oregon Health Sciences University, 1986


Residency:

  • Internal Medicine - University of California, San Francisco Affiliated Hospitals, 1986-1989
  • Chief Resident - Moffitt-Long Hospital, University of California, San Francisco , 1989-1990


Fellowship:

  • Pulmonary and Critical Care Medicine - University of California, San Francisco Affiliated Hospitals, 1992-1996


Research Interest:

  • Acute lung injury
  • Diagnostic and therapeutic techniques for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
  • Development of clinical care algorithms for patients with hereditary hemorrhagic telangiectasia.


Clinical Interest:

  • Critical care medicine, acute lung injury, hereditary hemorrhagic telangiectasia, pulmonary arteriovenous malformations,


Representative Publications:

  • Chesnutt M.S ., T.D. Dewar, R.M. Locksley (eds.): Office and Bedside Procedures. Appleton & Lange, Norwalk, CT, 1992.
  • Chesnutt M.S. , S.C. Lazarus. Asthma therapy in the nineties: Focus on inflammation. Hosp Formul. 27:466-485, 1992.
  • Graber M.L., Chesnutt M.S. Acute renal failure and electrolyte disturbances in the intensive care unit. In: M.A. Matthay, D.E. Schwartz, eds. Complications in the Intensive Care Unit. Chapman & Hall, New York, NY, 1997.
  • Sipple J., Chesnutt M.S. . Bronchoscopic therapy of bronchopleural fistulas. J Bronchology. 5:61-69, 1998.
  • Chesnutt M.S. , B.K. Finck, N. Killeen, M.K. Connolly, H. Goodman, D. Wofsy. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin Immunol Immunopath. 87:23-32, 1998.
  • Chesnutt M.S. Management of asthma exacerbation's. Clinical Cornerstone. 1:39-56, 1998.
  • Chesnutt M.S. , T.J. Prendergast. Lung. In: L.M. Tierney, S.J. McPhee, M.A. Papadakis, eds. Current Medical Diagnosis & Treatment 1999. Appleton & Lange, Stamford, CT, 1998.
  • Jeddi P., J. Keusch, P.M. Lydyard, K.B.V. Bodman-Smith, Chesnutt M.S., D. Wofsy, H. Hirota, T. Taga, P.J. Delves. The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G. Immunology. 98:475-480, 1999.
  • Wada T., A. Schwarting, M.S. Chesnutt, D. Wofsy, V.R. Kelley. Nephritogenic cytokines and disease in MRL-FASlpr kidneys are dependent on multiple T-cell subsets. Kidney Int. 59:565-578, 2001.
  • Chesnutt M.S. , T. Nuckton, J.A. Golden, H.G. Folkesson, M.A. Matthay. Rapid alveolar fluid clearance following lung lavage in patients with alveolar proteinosis. Chest 120:271-274, 2001.
  • Chesnutt M.S . Respiratory Failure. In: R. Carlson, M. Fink, J.A. Kruse, eds. The Saunders Manual of Critical Care. Saunders, Philadelphia, PA 2002.
  • Chesnutt, M.S., T.J. Prendergast. Lung. In: L.M. Tierney, S.J. McPhee, M.A. Papadakis, eds. Current Medical Diagnosis & Treatment 2006. Appleton & Lange, Stamford, CT 2005.


Biosketch:

Dr. Chesnutt is Associate Professor Medicine in the Division of Pulmonary and Critical Care at OHSU. In 1982, Dr. Chesnutt graduated summa cum laude with a degree in Chemistry from Pacific Lutheran University. He received his MD degree from Oregon Health Sciences University in 1986. He then completed a residency in Internal Medicine and a fellowship in Pulmonary and Critical Care Medicine at the University of California, San Francisco.

Dr. Chesnutt joined the Division of Pulmonary and Critical Care in 1996. In 2005, Dr. Chesnutt became the Medical Director of Critical Care at the Portland VA Medical Center. Dr. Chesnutt directs the OHSU Center for Intensive Care Research. His research interests include acute lung injury and sepsis.

Nationally recognized for his expertise on Hereditary Hemorrhagic Telangiectasia, Dr. Chesnutt helped establish an HHT Center of Excellence at OHSU in 1998. The OHSU HHT Center is part of a network of worldwide multi-disciplinary HHT Centers of Excellence. The OHSU HHT Center provides comprehensive screening and treatment for this complex genetic disorder. Dr. Chesnutt regulary gives presentations on the pulmonary manifestations of HHT including talks at the yearly HHT Foundation International Conference which is a forum for patients with this disorder and for physicians to learn about the evaluation and treatment of people with HHT.

Dr. Chesnutt has been invited to give numerous lectures and conference presentations at local, regional, national and international levels and has authored a variety of publications including the Lung chapter in the regularly updated text Current Medical Diagnosis & Treatment .

 

0